Hassan Fouad Huwait
Department of Pathology, Faculty of Medicine, Umm AL-Qura University, Makkah, Saudi Arabia
Anmar Mohammed Nassir
Department of Surgery, Faculty of Medicine, Umm AL-Qura University, Makkah, Saudi Arabia
Hanan Mohamed Abd Elmoneim
Department of Pathology, Faculty of Medicine, Minyia University, Minyia, Egypt
LiveDNA: 251.22941
Hala Fawzy Mohamed Kamel
Department of Biochemistry, Faculty of Medicine, Umm AL-Qura University, Makkah, Saudi Arabia
Nisreen Dahi Toni
Department of Pathology, Faculty of Medicine, Minyia University, Minyia, Egypt
Nada Adel Babtain
Faculty of Medicine, Umm AL-Qura University, Makkah, Saudi Arabia
Alaa Sami Barhamain
Faculty of Medicine, Umm AL-Qura University, Makkah, Saudi Arabia
Abdul Basit Sadiq Malibari
Faculty of Medicine, Umm AL-Qura University, Makkah, Saudi Arabia
Shrouk Fares Munassar
Faculty of Medicine, Umm AL-Qura University, Makkah, Saudi Arabia
Raneem Sami Rawa
Faculty of Medicine, Umm AL-Qura University, Makkah, Saudi Arabia
Ashwak Zahed Kufiah
Faculty of Pharmacy, Umm AL-Qura University, Makkah, Saudi Arabia
PDF Fulltext XML References Citation
How to cite this article
Hassan Fouad Huwait, Anmar Mohammed Nassir, Hanan Mohamed Abd Elmoneim, Hala Fawzy Mohamed Kamel, Nisreen Dahi Toni, Nada Adel Babtain, Alaa Sami Barhamain, Abdul Basit Sadiq Malibari, Shrouk Fares Munassar, Raneem Sami Rawa and Ashwak Zahed Kufiah, 2018. Clinical Significance and Potential Utility of Cancer Stem Cell Markers: ALDH1A1 and CD133 in Prostate Tumors. International Journal of Cancer Research, 14: 39-51.
DOI: 10.3923/ijcr.2018.39.51
URL: https://scialert.net/abstract/?doi=ijcr.2018.39.51
DOI: 10.3923/ijcr.2018.39.51
URL: https://scialert.net/abstract/?doi=ijcr.2018.39.51